Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon Academy - Biocon
Biocon engages law firm for governance review after CBI arrests
Biocon Biologics (@BioconBiologics) / Twitter
Biocon Campus - Biocon
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion | Mint
Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets | Deccan Herald
Biocon Campus - Biocon
Research Centre - Biocon
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
Biocon sells 5.4% stake in its research arm Syngene International - Hindustan Times
Biocon logo in transparent PNG format
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Biocon - Wikipedia
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Biocon Campus - Biocon
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources
Biocon Biologics enters licensing agreement with Yoshindo of Japan - The Hindu BusinessLine
Manufacturing Locations - Biocon
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
